Home >> Life Sciences >> Healthcare

Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Published: Apr-2016 | Format: PDF | Zion | Number of pages: 110 | Code: MRS - 55501

The report covers forecast and analysis for the metabolomics market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Million). The study includes drivers and restraints for the market along with the impact they have on the demand over the forecast period. Additionally, the report includes study of opportunities available in the metabolomics market on a global level.

In order to give the users of this report a comprehensive view on the metabolomics market, we have included a detailed competitive scenario, and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the metabolomics market has also been included. The study encompasses a market attractiveness analysis, wherein technology segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the metabolomics market is segmented on basis of technology, indication, application and region. High performance liquid chromatography, mass spectrometry, capillary electrophoresis, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Cardiology and oncology are the indication for metabolomics. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East and Africa with its further bifurcation into major countries including U.S. Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including company profiles of the key participants operating in the global market. Key players profiled in the report include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.

This report segments for metabolomics market as follows:

Metabolomics Market: Technology Segment Analysis

  • High performance liquid chromatography
  • Mass spectrometry
  • Capillary electrophoresis
  • Gas chromatography
  • Nuclear magnetic resonance spectroscopy

Metabolomics Market: Indication Segment Analysis

  • Cardiology
  • Oncology

Metabolomics Market: Application Segment Analysis

  • Drug discovery
  • Biomarker
  • Nutrigenomics

Metabolomics Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa
  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global market revenue, 2015 - 2021(USD Million)
    • 2.2. Global metabolomics market: Snapshot
  • Chapter 3. Metabolomics Market – Global and Industry Analysis
    • 3.1. Metabolomics : Market dynamics
    • 3.2. Market drivers
      • 3.2.1. Drivers of global metabolomics market: Impact analysis
      • 3.2.2. Development of metabolomics data analysis software
      • 3.2.3. Scope of toxicological studies and clinical trials
    • 3.3. Market restraints
      • 3.3.1. Restraints of global metabolomics market: Impact analysis
      • 3.3.2. Validation of the process
      • 3.3.3. Lack of adoption of metabolomics technology
    • 3.4. Opportunities
      • 3.4.1. Untapped demand from emerging economies
      • 3.4.2. Surging research and development expenditure
    • 3.5. Porter’s five forces analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by technology segment
      • 3.6.2. Market attractiveness analysis by indication segment
      • 3.6.3. Market attractiveness analysis by application segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Metabolomics Market - Competitive Landscape
    • 4.1. Company market share, 2015
    • 4.2. Price trend analysis
  • Chapter 5. Global Metabolomics Market – Technology Segment Analysis
    • 5.1. Global metabolomics market: technology overview
      • 5.1.1. Global metabolomics market revenue share, by technology, 2015 - 2021
    • 5.2. High performance liquid chromatography
      • 5.2.1. Global high performance liquid chromatography market, by technology, 2015 – 2021 (USD Million)
    • 5.3. Mass spectrometry
      • 5.3.1. Global mass spectrometry market, by technology, 2015 – 2021 (USD Million)
    • 5.4. Capillary electrophoresis
      • 5.4.1. Global capillary electrophoresis market, by technology, 2015 – 2021 (USD Million)
    • 5.5. Gas chromatography
      • 5.5.1. Global gas chromatography market, by technology, 2015 – 2021 (USD Million)
    • 5.6. Nuclear magnetic resonance spectroscopy
      • 5.6.1. Global nuclear magnetic resonance spectroscopy market, by technology, 2015 – 2021 (USD Million)
  • Chapter 6. Global Metabolomics Market – Indication Segment Analysis
    • 6.1. Global metabolomics market: indication overview
      • 6.1.1. Global metabolomics market revenue share, by indication, 2015 - 2021
    • 6.2. Cardiology
      • 6.2.1. Global cardiology market, by indication, 2015 – 2021 (USD Million)
    • 6.3. Oncology
      • 6.3.1. Global oncology market, by indication, 2015 – 2021 (USD Million)
  • Chapter 7. Global Metabolomics Market – Applications Segment Analysis
    • 7.1. Global metabolomics market: indication overview
      • 7.1.1. Global metabolomics market revenue share, by indication, 2015 - 2021
    • 7.2. Drug discovery
      • 7.2.1. Global drug discovery market, by indication, 2015 – 2021 (USD Million)
    • 7.3. Biomarker
      • 7.3.1. Global biomarker market, by indication, 2015 – 2021 (USD Million)
    • 7.4. Nutrigenomics
      • 7.4.1. Global nutrigenomics market, by indication, 2015 – 2021 (USD Million)
  • Chapter 8. Global Metabolomics market – Regional Segment Analysis
    • 8.1. Global metabolomics market: Regional overview
      • 8.1.1. Global metabolomics market revenue share by region, 2015 - 2021
    • 8.2. North America
      • 8.2.1. North America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.2.2. North America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.2.3. North America metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.2.3.1. U.S.
          • 8.2.3.1.1. U.S. metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.2.3.1.2. U.S. metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.2.3.1.3. U.S. metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe metabolomics market revenue, by a technology, 2015 – 2021 (USD Million)
      • 8.3.2. Europe metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.3.3. Europe metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.3.3.1. Germany
          • 8.3.3.1.1. Germany metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.3.3.1.2. Germany metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.3.3.1.3. Germany metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.3.3.2. France
          • 8.3.3.2.1. France metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.3.3.2.2. France metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.3.3.2.3. France metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.3.3.3. UK
          • 8.3.3.3.1. UK metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.3.3.3.2. UK metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.3.3.3.3. UK metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.4.2. Asia Pacific metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.4.3. Asia Pacific metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.4.3.1. China
          • 8.4.3.1.1. China metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.4.3.1.2. China metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.4.3.1.3. China metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.4.3.2. Japan
          • 8.4.3.2.1. Japan metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.4.3.2.2. Japan metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.4.3.2.3. Japan metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.4.3.3. India
          • 8.4.3.3.1. India metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.4.3.3.2. India metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.4.3.3.3. India metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.5.2. Latin America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.5.3. Latin America metabolomics market revenue, by application, 2015 – 2021 (USD Million)
        • 8.5.3.1. Brazil
          • 8.5.3.1.1. Brazil metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
          • 8.5.3.1.2. Brazil metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
          • 8.5.3.1.3. Brazil metabolomics market revenue, by application, 2015 – 2021 (USD Million)
    • 8.6. Middle East and Africa
      • 8.6.1. Middle East and Africa metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
      • 8.6.2. Middle East and Africa metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
      • 8.6.3. Middle East and Africa metabolomics market revenue, by application, 2015 – 2021 (USD Million)
  • Chapter 9. Company Profile
    • 9.1. Danaher Corporation
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. Bruker Corporation
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business strategy
      • 9.2.5. Recent developments
    • 9.3. Waters Corporation
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business strategy
      • 9.3.5. Recent developments
    • 9.4. Metabolon, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business strategy
      • 9.4.5. Recent developments
    • 9.5. Agilent Technologies
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business strategy
      • 9.5.5. Recent developments
    • 9.6. Thermo Fisher Scientific
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business strategy
      • 9.6.5. Recent developments
    • 9.7. Shimadzu Corporation
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business strategy
      • 9.7.5. Recent developments
    • 9.8. Others
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business strategy
      • 9.8.5. Recent developments

List of Tables

1. Global metabolomics market estimates and forecast, 2015 – 2021(USD Million)
2. Global metabolomics market, by region, 2015 – 2021(USD Million)
3. Global metabolomics market, by technology, 2015 – 2021(USD Million)
4. Global metabolomics market, by indication, 2015 – 2021(USD Million)
5. Global metabolomics market, by applications, 2015 – 2021(USD Million)
6. Metabolomics– Key market driver analysis
7. Metabolomics– Key market restraint analysis
8. North America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
9. North America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
10. North America metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
11. U.S. metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
12. U.S. metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
13. U.S. metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
14. Europe metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
15. Europe metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
16. Europe metabolomics market revenue, byapplications, 2015 – 2021 (USD Million)
17. Germany metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
18. Germany metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
19. Germany metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
20. France metabolomicsmarket revenue, by technology, 2015 – 2021 (USD Million)
21. France metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
22. France metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
23. UK metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
24. UK metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
25. UK metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
26. Asia Pacific metabolomicsmarket revenue, by technology, 2015 – 2021 (USD Million)
27. Asia Pacific metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
28. Asia Pacific metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
29. China metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
30. China metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
31. China metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
32. Japan metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
33. Japan metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
34. Japan metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
35. India metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
36. India metabolomicsmarket revenue, by indication, 2015 – 2021 (USD Million)
37. India metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
38. Latin America metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
39. Latin America metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
40. Latin America metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
41. Brazil metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
42. Brazil metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
43. Brazil metabolomics market revenue, by applications, 2015 – 2021 (USD Million)
44. Middle East and Africa metabolomics market revenue, by technology, 2015 – 2021 (USD Million)
45. Middle East and Africa metabolomics market revenue, by indication, 2015 – 2021 (USD Million)
46. Middle East and Africa metabolomics market revenue, by applications, 2015 – 2021 (USD Million)


List of Figures

1. Metabolomics market segmentation
2. Global metabolomics market revenue, 2015 – 2021(USD Million)
3. Metabolomics: Market attractiveness analysis, by technology segment
4. Metabolomics: Market attractiveness analysis, by indication segment
5. Metabolomics: Market attractiveness analysis, by applications segment
6. Metabolomics: Market attractiveness analysis, by regional segment
7. Global metabolomics marketer venue share by technology, 2015–2021
8. Global high performance liquid chromatography market, 2015 - 2021
9. Global mass spectrometry market, 2015–2021
10. Global capillary electrophoresis market, 2015–2021
11. Global gas chromatography market, 2015 – 2021
12. Global nuclear magnetic resonance spectroscopy market, 2015 – 2021
13. Global metabolomics market revenue share by indication, 2015 – 2021
14. Global cardiology market, 2015 - 2021
15. Global oncology market, 2015 – 2021
16. Global metabolomics market revenue share by applications, 2015–2021
17. Global drug discovery market, 2015 – 2021
18. Global biomarker market, 2015 – 2021
19. Global nutrigenomics market, 2015 – 2021
20. Global metabolomics market revenue share by region, 2015 – 2021

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Zion Research uses the synergy of combination of both primary research and secondary research for its research reports. For this study, we have conducted extensive primary research, wherein we have conducted in-depth interviews of the key opinion leader of this industry. Primary research make up for the biggest chunk of our data sources in addition to secondary research.

We referred to product literature of leading industry participants, annual reports, press releases, government publications, and other relevant sources for data collection and analysis thereof. Secondary research also includes a search of recent trade journals, technical writing, internet sources, and statistical data from government websites, trade associations and agencies.  

Zion Research has collected key data related to the Metabolomics Market and analyzed these data using a variety of methods. The market dynamics have been ascertained following a detailed study of the micro, meso, and macroeconomic indicators of the market.

This report is based on in-depth qualitative and quantitative analyses of the Global Metabolomics Market. The quantitative analysis involved the application of various projection and sampling techniques. The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions.

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically partake in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Based on the research results and technical insights thus gathered, Zion research analysts have provided a comprehensive analysis of the varied aspects of the market. The impact of global economic conditions and other macroeconomic indicators was also considered when assessing the market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Metabolism is the chemical reaction in the cell or tissue to maintain the living state of cell. Metabolism can be either anabolism or catabolism. Anabolism is the process in which compounds are synthesized that is required for cells to process, while breakdown of molecules for releasing energy is the catabolism. Metabolome is the set of metabolites like signaling molecules, hormones metabolic intermediates and secondary metabolites,present in a single organism. Metabolomics is study of chemical reactions related to metabolites and a field of analytical biochemistry.Metabolomics is used to quantify and identify the metabolites present in the cell by using the analytical technologies coupled with multi variant and statistical method for data interpretation.

Development of metabolomics data analysis software and biomarker screening of diseases metabolomics is used as diagnostic tool contributes to the splendid growth of metabolomics market. Moreover increasing scope of toxicological studies, clinical trials, rise in awareness for health and government and institution funds for researchdrives the demand for the metabolomics market. Validation of the process and lack of adoption of metabolomics technology is the major restrain of the metabolomics market. Untapped demand from emerging economies and surging research and development expenditure is likely to open new market avenues in the near future.

Metabolomics Market

The metabolomics market is segmented on basis of technology, indication, application and region.Mass spectrometry, capillary electrophoresis, high performance liquid chromatography, gas chromatography, and nuclear magnetic resonance spectroscopy are the technologies for metabolomics market. High performance liquid chromatography segment accounted highest share for metabolomics market. Applications include drug discovery, biomarker and nutrigenomics. Drug discovery emerged as potential segment owing to its important role in optimization, prioritization and drug target validation and identification for research. Cardiology and oncology are the indication for metabolomics.

With over 40%shares in total, metabolomics market was dominated by North America in 2015. This region is expected to be the fastest-growing market in near future. Europe was the second largest market for metabolomics in 2015. Asia Pacific is expected to witness rapid CAGR during the forecast period. The key players for the metabolomics market include Danaher Corporation, Bruker Corporation, Waters Corporation, Metabolon, Inc., Agilent Technologies, Thermo Fisher Scientific and Shimadzu Corporation among others.


Related Reports

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Steroid-Corticosteroids Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 124 | Code : MRS-166751 | 4880

Steroid-Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. Scope of the Report: This report focuses on the Steroid-Corticosteroids in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report co Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Saponin Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 121 | Code : MRS-166750 | 4880

Saponins are a class of chemical compounds found in particular abundance in various plant species. More specifically, they are amphipathic glycosides grouped phenomenologically by the soap-like foaming they produce when shaken in aqueous solutions, and structurally by having one or more hydrophilic glycoside moieties combined with a lipophilic triterpene derivative Scope of the Report: This report focuses on the Saponin in Global market, especially in North America, Europe and Asia-Paci Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Pine Needle Oil Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 122 | Code : MRS-166749 | 4880

Pine oil is an essential oil obtained by the steam distillation of stumps, needles, twigs and conesfrom a variety of species of pine, particularly Pinus sylvestris Scope of the Report: This report focuses on the Pine Needle Oil in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Ar Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Contact Lenses Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 117 | Code : MRS-166748 | 4880

Contact Lenses (CLs) are lightweight corrective, cosmetic or therapeutic devices that are usually placed directly onto the cornea of the eye. Contact lenses have many benefits for wearers, including appearance and practicality. Many people choose to wear contact lenses as opposed to eyeglasses as they do not steam up, they provide a wider field of vision, and they are more suitable for a number of sporting activities. Scope of the Report: This report focuses on the Contact Lenses in Glo Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Steam Sterilizer Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 121 | Code : MRS-166747 | 4880

This report is about the global steam sterilizer market. Steam sterilizer is a pressure chamber that is used to sterilize equipment and supplies. When placed inside the steam sterilizer, these items are exposed to high temperature steam (usually around 132 degrees Celsius or 270 degrees Fahrenheit) for about twenty minutes. This hot steam will kill germs that simple detergent or boiling water could not. Scope of the Report: This report focuses on the Steam Sterilizer in Global market, e Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Reverse Transcriptase Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 123 | Code : MRS-166746 | 4880

Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA. Scope of the Report: This report focuses on the Reverse Transcriptase in Global market, especiall Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Nebulizers Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 118 | Code : MRS-166745 | 4880

"Nebulizer is a medical device which converts the drug into mist and delivers it directly to the lungs. The technique of nebulization is commonly used for the treatment of respiratory diseases including asthma, cystic fibrosis and COPD. Various devices are used for nebulization. Devices that are rechargeable and electrically powered are the most widely used. This report mainly covers Nebulizers products used for hospital." Scope of the Report: This report focuses on the Nebulizers in Gl Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Mouth Ulcer Treatment Drug Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 120 | Code : MRS-166744 | 4880

Mouth ulcers, also known as canker sores, are normally small, painful lesions that develop in mouth or at the base of gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers aren’t contagious and usually go away within one to two weeks. Scope of the Report: This report focuses on the Mouth Ulcer Treatment Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on ma Read more

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Invisible Braces Market 2017 Forecast to 2022

Sep-2017 | Global Info Research | Pages : 123 | Code : MRS-166743 | 4880

Invisible Braces has revolutionized orthodontic treatment, allowing you to transform your smile discreetly and comfortably. It uses a series of virtually invisible custom-made aligners to gradually straighten your teeth without the need for metal wires or brackets. Scope of the Report: This report focuses on the Invisible Braces in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manu Read more

North America Organic and Natural Feminine Care Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Sep-2017 | Global Info Research | Pages : 122 | Code : MRS-166742 | 4480

This report studies the Organic and Natural Feminine Care market. Organic and Natural Feminine Care Product means Products made from soft, certified organic cotton and totally chlorine free, plastic free, biodegradable materials instead of synthetic chemical materials, these products only leave a soft footprint on the earth. They also, in general, provide a more comfortable using experience for the customers. Scope of the Report: This report focuses on the Organic and Natural Feminine Read more

Single User | $(USD)4199 View Pricing